Michael DePetris - 18 Apr 2022 Form 3 Insider Report for RVL Pharmaceuticals plc

Role: Principal Accounting Officer
Signature: By: /s/ Christopher Klein, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 18 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 22 Apr 2022, 16:15:32 UTC
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney